HomeKHRNF • OTCMKTS
add
Khiron Life Sciences Corp
Previous close
$0.00
Day range
$0.00 - $0.00
Avg Volume
96.76K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | 2021info | Y/Y change |
---|---|---|
Revenue | 12.80M | 59.60% |
Operating expense | 26.89M | -12.15% |
Net income | -33.13M | -37.81% |
Net profit margin | -258.92 | 13.65% |
Earnings per share | -0.12 | 49.67% |
EBITDA | -19.72M | 14.20% |
Effective tax rate | 1.38% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | 2021info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.92M | -58.78% |
Total assets | 42.27M | -42.23% |
Total liabilities | 8.94M | -10.10% |
Total equity | 33.33M | — |
Shares outstanding | 179.67M | — |
Price to book | 0.00 | — |
Return on assets | -22.22% | — |
Return on capital | -25.26% | — |
Cash Flow
Net change in cash
(CAD) | 2021info | Y/Y change |
---|---|---|
Net income | -33.13M | -37.81% |
Cash from operations | -20.40M | 16.85% |
Cash from investing | -2.09M | -108.39% |
Cash from financing | 10.90M | -10.50% |
Net change in cash | -12.73M | -203.43% |
Free cash flow | -11.48M | 38.42% |
About
Founded
May 16, 2012
Headquarters
Website
Employees
310